Sign In
Buy ENLV
$6.67
-0.190 (-2.77%)
At Close: Jul 13, 2026
Enlivex Therapeutics Earnings Calls
Jun 30, 2026
(Upcoming)
| Release date | Sep 04, 2026 |
| EPS estimate | -$0.0200 |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Expected change | +/- 10.58% |
Mar 31, 2026
-$3.45 (-666.67%)
| Release date | Mar 30, 2026 |
| EPS estimate | -$0.450 |
| EPS actual | -$3.45 |
| EPS Surprise | -666.67% |
| Revenue estimate | - |
| Revenue actual | - |
Dec 31, 2025
$410.25 (31,791.77%)
| Release date | Mar 25, 2026 |
| EPS estimate | -$1.29 |
| EPS actual | $410.25 |
| EPS Surprise | 31,791.77% |
| Revenue estimate | - |
| Revenue actual | - |
Sep 30, 2025
-$0.117 (93.50%)
| Release date | Dec 05, 2025 |
| EPS estimate | -$1.80 |
| EPS actual | -$0.117 |
| EPS Surprise | 93.50% |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for Enlivex Therapeutics
Below you can see how ENLV performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Sep 30, 2025
Beat
| Release date | Dec 05, 2025 |
| Price on release | $18.15 |
| EPS estimate | -$1.80 |
| EPS actual | -$0.117 |
| EPS surprise | 93.50% |
| Date | Price |
|---|---|
| Dec 01, 2025 | $13.79 |
| Dec 02, 2025 | $14.32 |
| Dec 03, 2025 | $16.35 |
| Dec 04, 2025 | $17.40 |
| Dec 05, 2025 | $18.15 |
| Dec 08, 2025 | $16.50 |
| Dec 09, 2025 | $15.38 |
| Dec 10, 2025 | $14.49 |
| Dec 11, 2025 | $14.56 |
| 4 days before | 31.66% |
| 4 days after | -19.76% |
| On release day | -9.09% |
| Change in period | 5.65% |
Dec 31, 2025
Beat
| Release date | Mar 25, 2026 |
| Price on release | $18.00 |
| EPS estimate | -$1.29 |
| EPS actual | $410.25 |
| EPS surprise | 31,791.77% |
| Date | Price |
|---|---|
| Mar 19, 2026 | $16.20 |
| Mar 20, 2026 | $15.30 |
| Mar 23, 2026 | $16.65 |
| Mar 24, 2026 | $16.50 |
| Mar 25, 2026 | $18.00 |
| Mar 26, 2026 | $16.35 |
| Mar 27, 2026 | $15.75 |
| Mar 30, 2026 | $13.50 |
| Mar 31, 2026 | $13.95 |
| 4 days before | 11.11% |
| 4 days after | -22.49% |
| On release day | -9.17% |
| Change in period | -13.88% |
Mar 31, 2026
Missed
| Release date | Mar 30, 2026 |
| Price on release | $13.50 |
| EPS estimate | -$0.450 |
| EPS actual | -$3.45 |
| EPS surprise | -666.67% |
| Date | Price |
|---|---|
| Mar 24, 2026 | $16.50 |
| Mar 25, 2026 | $18.00 |
| Mar 26, 2026 | $16.35 |
| Mar 27, 2026 | $15.75 |
| Mar 30, 2026 | $13.50 |
| Mar 31, 2026 | $13.95 |
| Apr 01, 2026 | $14.43 |
| Apr 02, 2026 | $14.28 |
| Apr 06, 2026 | $13.10 |
| 4 days before | -18.18% |
| 4 days after | -2.93% |
| On release day | 3.34% |
| Change in period | -20.58% |
Jun 30, 2026
(Upcoming)
| Release date | Sep 04, 2026 |
| Price on release | - |
| EPS estimate | -$0.0200 |
| EPS actual | - |
| Date | Price |
|---|---|
| Jul 07, 2026 | $7.41 |
| Jul 08, 2026 | $7.21 |
| Jul 09, 2026 | $7.40 |
| Jul 10, 2026 | $6.86 |
| Jul 13, 2026 | $6.67 |
Enlivex Therapeutics Earnings History
Earnings Calendar
FAQ
When is the earnings report for ENLV?
Enlivex Therapeutics Ltd. (ENLV) has scheduled its earnings report for Sep 04, 2026 after the markets close.
What is the ENLV price-to-earnings (P/E) ratio?
ENLV P/E ratio as of Jul 13, 2026 (TTM) is 0.0165.
What is the ENLV EPS forecast?
The forecasted EPS (Earnings Per Share) for Enlivex Therapeutics Ltd. (ENLV) for the first fiscal quarter 2026 is -$0.0200.
What are Enlivex Therapeutics Ltd.'s retained earnings?
On its balance sheet, Enlivex Therapeutics Ltd. reported retained earnings of $0 for the latest quarter ending Mar 31, 2026.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
